Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix (PECEP)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2010 by Maternal-Infantil Vall d´Hebron Hospital.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Maternal-Infantil Vall d´Hebron Hospital
Collaborators:
Hospital Materno-Infantil de Canarias
Hospital Son Llatzer
Institut Universitari Dexeus
Information provided by:
Maternal-Infantil Vall d´Hebron Hospital
ClinicalTrials.gov Identifier:
NCT00706264
First received: June 24, 2008
Last updated: September 14, 2010
Last verified: September 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Placement of a vaginal pessary reduces significantly the rate of spontaneous preterm birth in pregnant women with short cervical length at 18-22 weeks scan.
| Condition | Intervention | Phase |
|---|---|---|
|
Preterm Birth |
Device: Silicon ring (Arabin Pessary) |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Outcomes Assessor) Primary Purpose: Prevention |
| Official Title: | Randomized Controlled Trial: Prevention of Preterm Birth Using Cervical Pessary in Pregnant Women With Short Cervix (PECEP) |
Further study details as provided by Maternal-Infantil Vall d´Hebron Hospital:
Primary Outcome Measures:
- Spontaneous delivery before 34 completed weeks [ Time Frame: Each 6 months ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Birth weight, Fetal or Neonatal Death, Neonatal morbidity, Maternal adverse effects , Preterm birth before 37 weeks or 28 weeks, Rupture of membranes before 34 weeks, Hospitalisation for threatened preterm labour. [ Time Frame: Each 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 2780 |
| Study Start Date: | June 2007 |
| Estimated Study Completion Date: | June 2010 |
| Estimated Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: 1
Expectant management
|
|
|
Experimental: 2
Placement of arabin pessary since 23 weeks until 37 weeks
|
Device: Silicon ring (Arabin Pessary)
Placement of a silicon pessary in the vagina, around the cervix.
Other Name: Vaginal pessaries CE 0482 MED / CERT ISO 9003 /EN 46003
|
Detailed Description:
This trial includes pregnant women undergoing routine ultrasound examination at 18.0 to 22.6 weeks of gestation.
Eligibility| Ages Eligible for Study: | 18 Years to 45 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Singleton pregnancy
- Minimal age of 18 years
Exclusion Criteria:
- Major fetal abnormalities (requiring surgery or leading to infant death or severe handicap)
- SROM at the time of randomization
- Cervical cerclage in situ
- Active vaginal bleeding
- Previous cone biopsy or cerclage
- Major uterine structural anomalies
- Placenta previa
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00706264
Locations
| Spain | |
| Hospital Materno-Infantil de Canarias | |
| Las Palmas de Gran Canaria, Gran Canaria, Spain, 35016 | |
| Hospital de Reus | |
| Reus, Tarragona, Spain | |
| Hospital Vall d´Hebron | |
| Barcelona, Spain, 08035 | |
| Institut Universitary Dexeus | |
| Barcelona, Spain | |
| Hospital de Fuenlabrada | |
| Madrid, Spain | |
| Hospital Son Llàtzer | |
| Mallorca, Spain, 07198 | |
Sponsors and Collaborators
Maternal-Infantil Vall d´Hebron Hospital
Hospital Materno-Infantil de Canarias
Hospital Son Llatzer
Institut Universitari Dexeus
Investigators
| Study Director: | ELENA CARRERAS, PhD | Maternal-Infantil Vall d´Hebron Hospital |
More Information
No publications provided by Maternal-Infantil Vall d´Hebron Hospital
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Elena Carreras Moratonas / PhD, Maternal-Infantil Vall d´Hebron Hospital |
| ClinicalTrials.gov Identifier: | NCT00706264 History of Changes |
| Other Study ID Numbers: | PECEP-TRIAL |
| Study First Received: | June 24, 2008 |
| Last Updated: | September 14, 2010 |
| Health Authority: | Spain: Spanish Agency of Medicines |
Keywords provided by Maternal-Infantil Vall d´Hebron Hospital:
|
Short cervix preterm birth arabin pessary |
Additional relevant MeSH terms:
|
Premature Birth Obstetric Labor, Premature Obstetric Labor Complications Pregnancy Complications Silicon |
Trace Elements Micronutrients Growth Substances Physiological Effects of Drugs Pharmacologic Actions |
ClinicalTrials.gov processed this record on May 19, 2013